MedAdvisor Quarterly Report June 2016: Strong Operational Performance, Cash Receipts Totals $292k, Pharmacy Network and Number of Patients Increases

29th July 2016, ASX Announcement

Highlights

• Strong operational performance with an increase across all key revenue drivers
  – Over 180,000 patients using the platform as at 30 June 2016, a 132% increase on the prior corresponding period
  –  Expansion of pharmacy network by 33% on the prior corresponding period to over 1,600 pharmacies, encompassing over 30% of all Australian community pharmacies
  – Key partnerships with pharmaceutical manufacturers for Patient Engagement Programs (PEP)
• Cash receipts for the quarter totalled $292k, an increase of 7% on the previous March 2016 quarter
• Tap-To-Refill script ordering function continues to perform, becoming a key drover of patient engagement, with 40% of the user base currently utilising the function
•  MedAdvisor continues to expand its pharmacy network and increase the number of patients on the platform , driving transactional and subscription revenue

MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication management company, has today released its Appendix 4C Report for the three-month period to 30 June 2016 and is pleased to provide a review of the progress during the period.

To view the full announcement, please click on the button below.